Glycolytic enzyme inhibitors in cancer treatment

Author： Scatena Roberto   Bottoni Patrizia   Pontoglio Alessandro   Mastrototaro Lucia   Giardina Bruno  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1533-1545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Block Copolymer Micelles for Controlled Delivery of Glycolytic Enzyme Inhibitors

By Akter Shanjida   Clem Brian   Lee Hyun   Chesney Jason   Bae Younsoo  

Pharmaceutical Research, Vol. 29, Iss. 3, 2012-03 ,pp. : 847-855

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of prostate cancer

By Kluetz Paul G   Figg William D   Dahut William L  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 233-247

Informa Healthcare

Access to resources Recommend Favorite

Advances in Mitotic Inhibitors for Cancer Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 885-895

Bentham Science Publishers

Access to resources Recommend Favorite